Skip to Content

Get Your FREE Consultation

Blog

Monthly Archives: July 2012

CFPB Announces Plans to Simplify and Clarify Mortgage Disclosure Forms

July 31, 2012

As it approaches its one-year anniversary, the Consumer Financial Protection Bureau (“CFPB”) announced plans for overhauling the home mortgage market as a first step toward improving its fairness and clarity. The CFPB was created through the 2010 Dodd-Frank Act with a mission of helping ensure clarity and fairness in the […]

Learn More

Abbott Laboratories to Pay $1.6 Billion to Settle Deceptive Marketing Claims

July 31, 2012

Abbott Laboratories (“Abbott”) recently announced that it will pay $1.6 billion to settle various federal and state claims that it improperly marketed the prescription drug Depakote for off-label uses. Abbott will pay $800 million to resolve civil claims brought by the federal government and states, $700 million in criminal penalties, […]

Learn More

Joint Policy Committee Calls for Asbestos Ban

The Joint Policy Committee of the Societies of Epidemiology has issued a statement calling for a complete ban on the mining, export and use of asbestos. More than one hundred scientific, epidemiology and public health organizations have endorsed the statement. Unfortunately, despite the overwhelming knowledge in the medical and scientific […]

Learn More

NC Hospital Pays $1.9 Million to Settle Whistleblower Lawsuit

July 30, 2012

Rex Hospital, based in Raleigh, North Carolina, has agreed to pay the federal government $1.9 million to settle Medicare fraud charges. The qui tam (or “whistleblower”) lawsuit alleged that hospitals were keeping Medicare patients overnight unnecessarily following a back procedure known as “kyphoplasty.” The action alleged hospitals encouraged overnight stays […]

Learn More

J&J Agrees to $2.2 Billion Settlement of Unlawful Marketing Claims

Johnson & Johnson (“J&J”) has purportedly reached a settlement with the Justice Department which will have the healthcare giant paying $2.2 billion to resolve unlawful marketing claims. The settlement would include a criminal fine of approximately $400 million for the unlawful promotion of the antipsychotic drug Risperdal. The final total […]

Learn More

CFPB Proposes New Rule Requiring Transparent Mortgage Disclosures

July 27, 2012

The Consumer Financial Protection Bureau (“CFPB”) has submitted a proposed rule to the Federal Register that would create plain-English, more transparent mortgage disclosures. The proposal follows more than a year of research and analysis of mortgage disclosures and the best ways to ensure that customers receive needed information to make […]

Learn More

Whistleblowers Help Us All

July 24, 2012

In a time when it gets increasingly difficult for politicians to agree on regulations, reign in the cost of healthcare or control financial institutions, one strong person can make a difference. Under the False Claims Act any person, business or entity that defrauds the federal government of the American taxpayers’ […]

Learn More

American Banker Reports on Challenges to Lenders’ Force-Placed Insurance Practices

July 16, 2012

American Banker, the nation’s leading publication dealing with the banking industry, reported on mounting challenges to lenders’ alleged self-dealing with force-placed hazard or homeowner’s insurance. In addition to a number of lawsuits filed against banks and mortgage servicers across the country, regulatory authorities are now investigating whether banks are unfairly […]

Learn More

How Small Is Asbestos?

Asbestos fibers are tiny, so small that individual fibers cannot be seen by the naked eye. For asbestos fibers to be visible to the human eye, there must be thousands or even millions of fibers in the air. This typically happens in industrial environments, for example when a drywall worker […]

Learn More

Glaxo Settles Illegal Marketing Claims for $3 Billion

The British drug-maker GlaxoSmithKline agreed to pay $3 billion to settle claims related to illegal marketing of drugs. The U.S. government’s civil and criminal investigations of Glaxo related to multiple different drugs. The settlement includes resolution of allegations that Glaxo improperly marketed the drug Avandia, a drug whose use was […]

Learn More
TALK TO US NOW
FOR FREE
No Win, No Fee

Review Us

Martin & Jones, PLLC logo

“I would like to leave a testimonial thanking Steven and Allison for their care and understanding. Steven’s pursuit and success in getting some compensation for our loss. A final closure of our loss of brother Mike. Thanks to Martin & Jones for looking after Mike’s care since his injury in 2005. You have been there for Mike and his family for a long time. Mike passed in 2016 and you stood for the family up to the present (July 2017). Many thanks.”

Contact Our North Carolina Personal Injury Law Firm

for a Consultation for Your Accident or Medical Malpractice Claim

Call us at 800-662-1234
TALK TO US NOW
FOR FREE
No Win, No Fee

The law firm you choose makes a difference. If you are the victim of an accident or an illness that someone else caused, the North Carolina personal injury law firm of Martin & Jones has the depth of experience, skills and sensitivity to make your road to recovery as smooth as possible. Whether you have experience with the legal system or have never hired a medical malpractice or personal injury lawyer before, our attorneys and staff will do our best to answer your questions, provide clear advice and prepare you and your family for what to expect. If you would like more information or to meet with one of our attorneys, please fill out the form below or call us at 800.662.1234.